Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 2 April 2020, 15:30 HKT/SGT
Share:
    

Source: TNB AURA
TNB Aura launches Special Situations Fund, backing tech startups with US$2M each

SINGAPORE, Apr 2, 2020 - (ACN Newswire) - WHO declared COVID-19 a pandemic, its message balancing the inevitability of the virus' global ramifications, with the observation that governments, businesses, and individuals still possess the critical ability to alter the outbreak's trajectory. With businesses abruptly curtailing operations across most sectors, only a select set of companies are well positioned to take advantage of the current situation, while the majority are not.

TNB Aura Co-founders and Managing Partners Vicknesh R Pillay and Charles Wong.


TNB Aura has launched a new Special Situations Fund, backing tech companies impacted by the pandemic with ~US$2M each.

"While we continue investing in growth companies in South East Asia via our first fund, and soon to be second, we see an opportunity to support great companies which are facing near-term cash flows issues as a result of The COVID-19 black swan event," Co-founder and Managing Partner, Vicknesh R Pillay commented. "Our highly selective and hands on approach to investing has proven resilient, reflecting as such in a majority of our portfolio companies. With our financial acumen, we assist our investee companies to be nimble in the manner in which they manage their cash flow, budgeting and talent optimization through volatility."

By providing an extended runway of 12-18 months to weather the headwinds, the fund serves to aid companies in returning their focus to achieving their targeted milestones. "We are investing for the long term, and seek to provide an encouraging narrative to the ecosystem at this critical time. Ultimately, we believe in strong fundamentals, and in the ability of selected companies to both weather the current storm and come out stronger on the other side," said Co-founder and Managing Partner, Charles Wong.

"With the market having previously witnessed a glut of over-valued deals, and today, a current value dislocation, TNB AURA is targeting value deals of high quality for this new fund," Pillay added. TNB AURA aims to turnaround funding within 1-2 months, with the fund open to a range of funding structures such as convertible notes or direct equity. For all interested applicants, please apply through the Special Situations Fund Form. All applications will be dealt with, with the highest confidentiality.

About TNB Aura
TNB Aura is a Singapore headquartered venture capital firm focused on Series A and B technology investments in the region. Founded by entrepreneurs and fund managers who have established, grown and exited several businesses, TNB Aura looks to become the marquee venture capital fund in South East Asia. We believe in people and companies with strong fundamentals, and invest $1mil-$5mil into the next wave of technology-led high growth companies.

For further information, please contact:
Vicknesh R Pillay
Managing Partner, TNB Aura
E: vicknesh@tnbaura.com
M: +65 9009 6164

Charles Wong
Managing Partner, TNB Aura
E: charles.wong@aura.co
M: +65 8250 2525


Topic: Press release summary
Source: TNB AURA

Sectors: Blockchain Technology, PE, VC & Alternatives
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
OSL Lists State-Supervised Gold-Backed Stablecoin USDKG as Platform Expands Asia's Digital Asset Ecosystem  
May 22, 2026 22:30 HKT/SGT
Six Factors to Consider When Opting for a Credit Line in Singapore  
May 22, 2026 19:05 HKT/SGT
Patents Build Solid Barriers, Technologies Achieve All-Round Breakthroughs, New Vision Leads the New Track of AR Interaction  
May 22, 2026 17:46 HKT/SGT
GTJAI Won Two Awards at HR Asia 2026  
May 22, 2026 10:49 HKT/SGT
Everest Medicines Receives Shareholding Increase from Substantial Shareholder CBC Group, Global Expansion Expected to Benefit  
May 22, 2026 10:05 HKT/SGT
Eisai Deepens Body of Clinical Evidence for LENVIMA(R) (Lenvatinib) Across Established Indications at ASCO 2026  
Thursday, May 21, 2026 11:23:00 PM
Honda to Begin Sales of Super-ONE Compact EV  
Thursday, May 21, 2026 11:16:00 PM
GA-ASI Completes First Flight of MQ-9B With AEW Pods  
May 21, 2026 23:00 HKT/SGT
The World's First Global Energy Drink Ranking Accidentally Revealed Something Much Bigger  
May 21, 2026 18:50 HKT/SGT
OneRobotics Launches World Action Model OneModel 1.7, Achieving 99% Success in Real-Robot Tests  
May 21, 2026 17:41 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: